A 35-year-old male with cystic fibrosis presents with chronic productive cough and recurrent respiratory infections. Sputum culture grows mucoid, greenish colonies on MacConkey agar that are oxidase-positive. To assess antimicrobial susceptibility and guide antibiotic therapy, which investigation is most appropriate for this patient?

## Antimicrobial Susceptibility Testing for Pseudomonas aeruginosa ### Clinical Context: Why Susceptibility Testing Matters **Key Point:** P. aeruginosa is an opportunistic pathogen with intrinsic resistance to many antibiotics and high propensity for acquiring resistance during therapy. Susceptibility testing is mandatory to guide appropriate antibiotic selection, especially in chronic infections like cystic fibrosis. ### Kirby-Bauer Disk Diffusion — The Standard Method **High-Yield:** The Kirby-Bauer disk diffusion method on Mueller-Hinton agar is the most widely used, cost-effective, and standardized method for P. aeruginosa susceptibility testing in routine clinical microbiology laboratories. It is recommended by CLSI (Clinical and Laboratory Standards Institute) and is the first-line method globally. ### Why Mueller-Hinton Agar? **Clinical Pearl:** Mueller-Hinton agar is the only medium recommended for disk diffusion testing because it: - Has a consistent, non-inhibitory composition - Allows uniform diffusion of antibiotics - Provides reproducible and reliable zone measurements - Is pH-neutral (pH 7.2–7.4) ### Comparison of Susceptibility Testing Methods | Method | Medium | Advantages | Disadvantages | Clinical Use | | --- | --- | --- | --- | --- | | **Kirby-Bauer (Disk Diffusion)** | Mueller-Hinton | Cost-effective, rapid (24 h), standardized, routine labs | Semi-quantitative, requires interpretation | **First-line, routine** | | **E-test (Gradient Diffusion)** | Mueller-Hinton | Quantitative MIC, good for resistant strains | More expensive, slower | Backup for resistant isolates | | **Broth Microdilution** | Broth | Quantitative MIC, reference method | Labor-intensive, expensive, requires automation | Reference labs, research | | **Chromogenic Substrate** | N/A | Detects specific enzymes (e.g., β-lactamase) | Limited to enzyme detection, not full susceptibility | Adjunct, not standalone | ### Workflow for P. aeruginosa Susceptibility Testing ```mermaid flowchart TD A[P. aeruginosa isolated]:::outcome --> B[Prepare inoculum on Mueller-Hinton agar]:::action B --> C[Apply antibiotic disks]:::action C --> D[Incubate 24 hours at 35°C]:::action D --> E[Measure zone diameters]:::action E --> F{Interpret vs CLSI breakpoints}:::decision F -->|Susceptible| G[Report susceptible]:::outcome F -->|Intermediate| H[Consider E-test or broth microdilution]:::action F -->|Resistant| I[Report resistant; consider alternative agents]:::outcome ``` ### Why Not E-test or Broth Microdilution as First-Line? **Tip:** While E-test and broth microdilution provide quantitative MIC (minimum inhibitory concentration) values, they are: - More expensive - More time-consuming - Not necessary for routine clinical decision-making in most cases - Reserved for resistant isolates or when quantitative data is critical **Mnemonic:** **DISK-FIRST** = DIsk diffusion is FIRST-line for routine P. aeruginosa susceptibility ### Antibiotics Tested for P. aeruginosa **Key Point:** Standard panel for P. aeruginosa includes: - Antipseudomonal β-lactams: piperacillin-tazobactam, ceftazidime, cefepime, meropenem - Fluoroquinolones: ciprofloxacin, levofloxacin - Aminoglycosides: gentamicin, tobramycin, amikacin - Others: aztreonam, colistin (for highly resistant strains) ### Why Not Chromogenic Substrate Test? Chromogenic substrate tests (e.g., for β-lactamase detection) are adjunctive tools that detect specific resistance mechanisms but do NOT provide comprehensive susceptibility data. They cannot replace full susceptibility testing.